Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Short-term reductioidin bone markers with high-dose simvastatin
Robert S. Rosenson
, Christine C. Tangney
, Craig B. Langman
, Thomas S. Parker
, Daniel M. Levine
, Bruce R. Gordon
Research output
:
Contribution to journal
›
Article
›
peer-review
35
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Short-term reductioidin bone markers with high-dose simvastatin'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
High Dose
100%
Bone Turnover Markers
100%
Simvastatin
100%
Bone Alkaline Phosphatase
60%
Treatment Regimen
40%
Bone Turnover
40%
N-telopeptide
40%
Type I Collagen
20%
Mean Standard Deviation
20%
Placebo
20%
Bone Mass
20%
Non-smoking
20%
Statins
20%
Body Mass Index
20%
Osteocalcin
20%
Blood Samples
20%
Cholesterol Levels
20%
Bone Fracture
20%
Atorvastatin
20%
Statin Therapy
20%
Low-density Lipoprotein Cholesterol (LDL-C)
20%
Bone Resorption
20%
Bone Serum Markers
20%
Fracture Rate
20%
Mass Rate
20%
Serum Bone Markers
20%
Short-term Use
20%
Immunology and Microbiology
Drug Megadose
100%
Phosphatase
100%
Cross Linking
66%
Bone Turnover
66%
Body Mass
33%
Bone Mass
33%
Osteolysis
33%
Low-Density Lipoprotein
33%
Pharmacology, Toxicology and Pharmaceutical Science
Simvastatin
100%
Alkaline Phosphatase
60%
Telopeptide
40%
Placebo
20%
Statin (Protein)
20%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
20%
Osteocalcin
20%
Collagen Type 1
20%
Pravastatin
20%
Low Density Lipoprotein Cholesterol
20%